B&L Looks To Zyoptix, Eyetracking System to Boost Refractive Market Share
This article was originally published in The Gray Sheet
Executive Summary
Bausch & Lomb will incorporate its Active Eyetracking high-speed image processing system into all Technolas 217A excimer lasers sold after November at no additional cost.
You may also be interested in...
Refractec ViewPoint Comparative Claims Questioned During Panel Review
Reservations raised by FDA's Ophthalmic Devices Panel regarding claims by Refractec about the less invasive nature of its ViewPoint conductive keratoplasty (CK) system compared with LASIK highlight the challenges the firm may face in differentiating its product from other refractive devices for treating hyperopia
Refractec ViewPoint Comparative Claims Questioned During Panel Review
Reservations raised by FDA's Ophthalmic Devices Panel regarding claims by Refractec about the less invasive nature of its ViewPoint conductive keratoplasty (CK) system compared with LASIK highlight the challenges the firm may face in differentiating its product from other refractive devices for treating hyperopia
B&L Eyes Zyoptix Per-Procedure Fees To Recoup LASIK Royalties To Visx
Bausch & Lomb will look to its Zyoptix eye diagnostic system to eventually offset royalty payments to LASIK competitor Visx.